Investigating the link between MRI findings and symptoms in endolymphatic hydrops
Official title: Study of the Radio-clinical Correlation of Endolymphatic Hydrops
Run by University Hospital, Strasbourg, France · NCT06910865 · Data updated 2026-11-12
This study is trying to see if the changes found on MRI scans in adults with endolymphatic hydrops match up with the symptoms they experience.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University Hospital, Strasbourg, France Academic / other |
| Locations | 1 site (Strasbourg) |
| Status | Recruiting |
| Started | July 19, 2024 |
| Main results expected | December 19, 2025 |
| Study ends | December 19, 2025 |
| Registry record updated | April 4, 2025 |
| Trial ID | NCT06910865 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older who show signs of vestibular dilation on MRI.
✕Probably not a fit
Patients who do not have vestibular dilation on MRI or those who oppose the reuse of their data for research will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to explore the correlation between radiological signs of endolymphatic hydrops observed on MRI and the clinical symptoms presented by patients. By selecting adult participants who exhibit vestibular dilation on MRI, the study will analyze how these imaging findings relate to the patients' vestibular clinical signs. The goal is to better understand the relationship between the imaging results and the clinical manifestations of the condition, which has not been previously investigated.
Why it matters
Potential benefit: If successful, this study could enhance the diagnostic accuracy and treatment approaches for patients with endolymphatic hydrops.
How similar studies have gone: This study addresses a novel aspect of endolymphatic hydrops, as no prior studies have specifically investigated the radiological-clinical correlation in this manner.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult subject (≥18 years) * Subject presenting vestibular dilation on MRI Exclusion Criteria: * Subjects who have expressed opposition to the reuse of their data for scientific research purposes. * Subjects under legal protection * Subjects under guardianship or curatorship
Where it's running
-
Service d'ORL et de Chirurgie Cervico-faciale - CHU de Strasbourg - France
Strasbourg, France Recruiting
Study contacts
- Study coordinator: Christian DEBRY, MD, PhD
- Email: christian.debry@chru-strasbourg.fr
- Phone: 33 3 88 12 76 44
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Patient-specific biomechanical modeling of incisional hernias with AI and finite element analysis
Researchers will test a personalized computer model of the abdominal wall for adults with incisional hernias using anonymized CT data and AI to see how the hernia shapes relate to tissue mechanics.
-
Menin inhibitors in pediatric relapsed or refractory acute leukemia
This study looks at kids with relapsed or treatment-resistant acute leukemia who have specific genetic changes and are treated with menin inhibitors to see how they fare.
-
Long-Term Epilepsy Outcomes in Children After Perinatal Stroke
This study looks at how epilepsy progresses in kids who had a stroke before 28 days old to see how their seizures and syndromes evolve over time.
-
Predictors of Success and Failure of v-NOTES Hysterectomy for Large Uteri
This study looks at which factors predict whether a v-NOTES hysterectomy for large uteri will be completed without needing to switch to another surgical approach.
-
Prehospital end-of-life care: how professionals use a comfort care booklet in Strasbourg
This study tests how emergency crew members in Strasbourg use a comfort care booklet when caring for patients at end of life, and what they think about it.
-
Toxicity of intensive first-line treatment for adult Burkitt lymphoma
This study looks back at adult Burkitt lymphoma patients treated with very aggressive first-line chemotherapy to see how toxic the treatment is and what their long-term outcomes were.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.